Skip to Content

Danyelza Prices, Coupons and Patient Assistance Programs

Danyelza (naxitamab) is a member of the miscellaneous antineoplastics drug class and is commonly used for Neuroblastoma.

Danyelza Prices

The cost for Danyelza intravenous solution (4 mg/mL) is around $21,274 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Danyelza price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Intravenous Solution

4 mg/mL Danyelza intravenous solution
from $21,273.69 for 10 milliliters
Quantity Per unit Price
10 milliliters $2,127.37 $21,273.69

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Danyelza Coupons and Rebates

Danyelza offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Danyelza Y-mAbs Connect Co-pay Program: Eligible patients may have their out-of-pocket costs reduced when enrolled in the program; for additional information contact the program at 833-339-6227.

Applies to:Danyelza
Number of uses:Contact the program

Patient Assistance Programs for Danyelza

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Y-mAbs Connect Patient Support Program

Elligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Medically Necessary as determined by a Doctor
  4. Must be residing in the US or US territory
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.

Applicable drugs:

  • Danyelza (naxitamab-gqgk) Injection; IV